公司資訊
基本資料 董監事 營業項目 公司歷程 關係企業 員工人數
財務相關資訊
財務報表 動產抵押 存款不足之退票事宜 選舉收入(政治獻金) 選舉支出(政治獻金)
業務相關資訊
標案拒往 進出口資料 商標 專利 政府標案
法律相關資訊
裁判書查詢 勞權違規 相關法律事務所 污染源裁處
相關新聞資訊
相關新聞
大江生醫股份有限公司 Approved
最後更新時間 ：2025/07/18 , 07:14 AM
最後更新時間 ：2025/07/18 , 07:14 AM
負責人
Lin,Yong-Xiang
統一編號
12292039
成立日期
1980/08/22
資本額
NT$3,000,000,000
實收資本額
NT$1,177,288,300
股票代號
8436
電話
02-87977811
地址
8F, No. 187, Gangcian Rd., Neihu Dist., Taipei City, 114, Taiwan
網站
http://www.tci-bio.com/
董監事
姓名 職稱 持有股份 代表法人
Lin,Yong-Xiang Chairman 5.77% YONG JIANG INVESTMENT CO., LTD.
YANG GUANG INVESTMENT CO., LTD. Director 3.39%
Chen,Jing-Ting Director 2.15% Maxigen Biotech Inc.
Gao,Zhen-Yi Independent Director 0.00%
Liao,Song-Yuan Independent Director 0.00%
Vacancy Independent Director
He,Shu-Min Independent Director 0.00%
營業項目
  • Manufacture of health supplements(089800)
  • Wholesale of Other Food(454920)
    • 公司歷程
  • Change Company Name to DAJIANG BIOMEDICAL CO., LTD. (FORMER NAME: DAJIANG XINGYE CO., LTD.)
    2022/10/04
  • Change Company Name to TCI CO., LTD.
    2022/10/04
  • Change Company Name to DAJIANG BIOMEDICAL CO., LTD. (FORMER NAME: DAJIANG XINGYE CO., LTD.)
    2022/04/18
  • Change Company Name to TCI CO., LTD.
    2022/04/18
  • Change Capital to 3,000,000,000
    2020/08/04
  • Change Capital to 2,000,000,000
    2018/08/23
  • Change Person in Charge to Lin,Yong-Xiang
    2017/06/01
  • Change Capital to 1,000,000,000
    2014/08/15
    • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 1,586,954 7,240,266 8,015,649
    Operating cost 919,742 4,062,460 4,799,114
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 667,212 3,177,806 3,216,535
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 667,212 3,177,806 3,216,535
    Operating expenses 492,346 2,150,079 2,161,937
    Other gain (loss), net - - -
    Operating profit (loss) 174,866 1,027,727 1,054,598
    Non-operating income and expenses 31,390 106,736 120,097
    Net profit (loss) before tax 206,256 1,134,463 1,174,695
    Income tax expense (benefits) 42,247 160,735 182,631
    Net profit (loss) of ongoing business for the current period 164,009 973,728 992,064
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 164,009 973,728 992,064
    Other comprehensive profit (loss), net 74,347 131,619 -81,883
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 238,356 1,105,347 910,181
    Net profit (loss) attributable to owners of parent company 136,870 851,499 896,258
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 27,139 122,229 95,806
    Comprehensive profit (loss) attributable to owners of parent company 212,467 981,148 806,835
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 25,889 124,199 103,346
    Basic earnings per share (yuan) 1 7 7
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 363,241 1,480,562 1,905,226
    Net cash inflows (outflows) from investing activities -101,931 -810,511 -377,959
    Net cash inflow (outflow) from financing activities 14,779 -1,227,668 -1,973,702
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 51,199 -38,597 -122,933
    Increase (decrease) in cash and cash equivalents in the current period 327,288 -596,214 -569,368
    Beginning balance of cash and cash equivalents 4,767,212 5,363,426 5,932,794
    Ending balance of cash and cash equivalents 5,094,500 4,767,212 5,363,426
    項目 2025 2024 2023
    Current asset 7,852,096 7,681,936 7,885,412
    Non-current asset 6,020,620 6,032,809 6,216,091
    Total asset 13,872,716 13,714,745 14,101,503
    Current liability 4,141,509 2,825,526 3,280,013
    Non-current liability 1,299,073 1,401,043 943,548
    Total liability 5,440,582 4,226,569 4,223,561
    share capital 1,182,608 1,182,608 1,182,608
    Equity - secruity token - - -
    capital reserve 2,496,713 2,893,400 2,900,420
    retained earning 3,985,013 4,684,018 4,656,525
    Other equity -78,383 -153,980 -283,533
    Treasury stock -516,029 -509,948 -232,963
    Total equity attributable to owners of parent company 7,069,922 8,096,098 8,223,057
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 1,362,212 1,392,078 1,654,885
    Total Equity 8,432,134 9,488,176 9,877,942
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 7,625,000 7,563,000 3,063,000
    Net asset value per share 63 73 71
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    Chattel mortgage TCI CO., LTD. 12292039 2020/07/22 2030/07/21 TAIWAN LAND BANK CO., LTD. 03700301 NT$720,000,000
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額 0
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額 0
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    2024 01-04 8~9M >10M
    2023 01-12 >10M >10M
    請下載完整報告 請下載完整報告 請下載完整報告 請下載完整報告
    請下載完整報告 請下載完整報告 請下載完整報告 請下載完整報告
    請下載完整報告 請下載完整報告 請下載完整報告 請下載完整報告
    商標
  • ClpBiotic
  • OAT IN ONE
  • We!設計字
  • Explorer設計字
  • F RMULA
  • Flora Chloris
  • BESTIME設計字
  • 標章圖
  • T.fibre
  • ProtoColla
    • 專利
  • 丹鳳牡丹萃取物用於製備皮膚調理組合物的用途
  • 益生菌組合及其用於腸胃道保健或調節免疫力的用途
  • 益生菌組合及其用於腸胃道保健或調節免疫力的用途
  • 金針花萃取物用於製備提升抗醣化活性組成物的用途
  • 黃金百香果發酵物用於改善肌膚狀態及抗光老化的用途
  • 龍膽萃取物用於製備頭皮保健的組合物的用途
  • 白玉石榴萃取物用於製備提升陰道內益生菌數量組合物的用途
  • 清酒乳桿菌以及其或其代謝產物用於改善膚況的用途
  • 益生質組合物及其用途
  • 富含菸醯胺單核苷酸的酵母粉的製備方法、酵母粉及其改善肌膚狀況、頭髮護理、抗發炎、心血管保健、抗氧化、抗老化及/或改善身體疲憊程度之用途
    • 政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    台酒生技葉黃素軟膠囊瓶裝及體驗包議價案 臺灣菸酒股份有限公司屏東酒廠 107/08/22 是
    375159-12台酒生技深海魚油軟膠囊15000瓶議價案 臺灣菸酒股份有限公司屏東酒廠 105/11/23 是
    385104-12台酒生技葡萄糖胺複方錠15,000瓶議價案 臺灣菸酒股份有限公司屏東酒廠 105/11/23 是
    多元茄紅南瓜子油軟膠囊議價案 臺灣菸酒股份有限公司屏東酒廠 105/11/04 是
    台酒生技葉黃素軟膠囊瓶裝及體驗包議價案 臺灣菸酒股份有限公司屏東酒廠 105/10/19 是
    強關錠4,000瓶增購案 臺灣菸酒股份有限公司桃園酒廠 105/01/27 是
    台酒生技深海魚油膠囊5,000瓶增購 臺灣菸酒股份有限公司桃園酒廠 105/01/19 是
    台酒生技深海魚油膠囊5,000瓶購置案 臺灣菸酒股份有限公司桃園酒廠 104/02/25 是
    強關錠4,000瓶購置 臺灣菸酒股份有限公司桃園酒廠 104/02/25 是
    強關錠4,000瓶購置 臺灣菸酒股份有限公司林口酒廠 103/03/11 是
    多元茄紅南瓜子油4,000盒購置 臺灣菸酒股份有限公司林口酒廠 102/11/20 否
    裁判書查詢
  • Others
    2020
  • Request for damage compensation
    2021
  • Infringement of copyright related property rights disputes
    2019
  • Payment order
    2007, 2008, 2020
  • Pay for the goods
    2006, 2007, 2008, 2009
  • Trademark Evaluation
    2016, 2017
  • Trademark opposition
    2016, 2017, 2020
  • Promissory note ruling
    2007
  • Invalidating Judgment (Note)
    2014
  • Petition filed for public summons
    2014, 2020, 2021
    • 勞權違規
    日期 違反法規法條 罰鍰金額
    2024/04/09 Paragraph 1, Article 6 of the Occupational Safety and Health Act
    2024/04/08 Paragraph 1, Article 24 of the Labor Standards Act 50,000
    2024/03/06 Paragraph 1, Article 24 of the Labor Standards Act; Paragraph 2, Article 32 of the Labor Standards Act; Paragraph 1, Article 36 of the Labor Standards Act 210,000
    2024/01/08 Paragraph 1, Article 6 of the Occupational Safety and Health Act
    2019/11/04 Paragraph 1, Article 23 of the Occupational Safety and Health Act
    2019/11/04 Paragraph 1, Article 22 of the Occupational Safety and Health Act
    2018/12/04 Paragraph 2, Article 32 of the Labor Standards Act; Paragraph 1, Article 36 of the Labor Standards Act
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
  • Find a Company
    City
    Taipei City Keelung City New Taipei City Lienchiang County Yilan County Hsinchu City Hsinchu County Taoyuan City Miaoli County Taichung City Changhua County Nantou County Chiayi City Chiayi County Yunlin County Tainan City Kaohsiung City Penghu County Kinmen County Pingtung County Taitung County Hualien County
  • Trending Companies
    新加坡商蝦皮娛樂電商有限公司(Shopee Taiwan Private Limited) 新加坡商蝦皮娛樂電商有限公司台灣分公司 兆億有限公司 震傳媒股份有限公司 聰明的家股份有限公司 思妍有限公司 弘潔科技股份有限公司 下半場電影股份有限公司 宏盛生技股份有限公司 泰暘企業行
    • 本頁內所載之資料，所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態，我們馬上通知你，追蹤公司讓你不錯過任何更新。